EoE KIDS: Higher Exposure Dupilumab Improves Histologic, Endoscopic Outcomes
Higher exposure dupilumab significantly improved histologic and endoscopic outcomes in children with EoE aged 1 to <12 years.
Source: hcplive.com
Endoscopic Outcomes News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Endoscopic Outcomes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Endoscopic Outcomes Today - Breaking & Trending Today
More Relief for Crohn's on the Horizon With New Treatments
IBD doesn't have a cure, and treatments are often limited. But, in recent years, gastrointestinal researchers have sharply focused on solutions for the disease overall and Crohn's in particular.
Source: medscape.com
Prospects for Crohn's Relief Brighten With New Advancements
More than 1 million Americans live with Crohn’s, a chronic and sometimes crippling bowel disease that affects the intestines and leads to digestive issues. But in 2024, breakthroughs could bring relief in different ways. Here's what to know.
Source: webmd.com
Abbvie Successful Phase 3 Study for Upadacitinib in Patients with Crohn's Disease
(PLX AI) - Abbvie Second Phase 3 Induction Study Confirms Upadacitinib (RINVOQ) Improved Clinical and Endoscopic Outcomes in Patients with Crohn's Disease.• In U-EXCEL, the second of two Phase 3 induction
Source: finanznachrichten.de
Abbvie Successful Phase 3 Study for Upadacitinib in Patients with Crohn's Disease
24.02.2022 - (PLX AI) – Abbvie Second Phase 3 Induction Study Confirms Upadacitinib (RINVOQ) Improved Clinical and Endoscopic Outcomes in Patients with Crohn's Disease.In U-EXCEL, the second of two Phase 3 induction studies, a significantly higher proportion of ...
Source: wallstreet-online.de